michelcarroll/llama2-earnings-stock-prediction-fine-tune huggingface dataset:
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Good morning, Aldo.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Great. Thank you. The IR team is available for follow-up discussions. And thank you for your time and interest in Campbell Soup Company.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
So, Louie, we will provide you with a lot more details in our next earnings conference call when we go into detailed summary of our outlook for fiscal year '22. We believe that the current preliminary numbers that we provided you because of the significant strategic moves that we've made that has an impact on our next fiscal year, we felt that this was -- this level of visibility at this time was critical for shareholders and analysts. In general, I can tell you that we have a very large portfolio of opportunities, both in our core businesses and in our acquired businesses that we're integrating with the rest of our businesses. Our position in the space is incredibly strong.
Our breadth and depth of our portfolio of opportunities is pretty large and diversified. We're very fortunate to have access to such large opportunities at various different ends of the spectrum and I believe that we're uniquely positioned against all other competitors in the space to provide a multi-domain, intelligent robotic system solution coupled with AI and autonomy and artificial intelligence capabilities. So as you saw from our comments, revenue range of about $560 million to $580 million is a significant growth on our current numbers and obviously, a very strong growth in our non-GAAP earnings per diluted share going all the way up to $2.50 and $2.70 range. So we look forward to providing you more details on the next call.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Hi Dan.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yeah, good morning, Adam. Yes, thanks for the question. And you know we're in a little bit of a quiet period here as we go through the various regulatory approvals. That said, one of the areas that we focus very quickly was feedback and I would just tell you it's been really, really positive on both fronts. So our customers at CDW are delighted about the acquisition and really looking forward to the combined entity, and the capabilities that they help bolster CDW given their reputation in the market in the quality of their -- of their services. And the reciprocal is true as well I talk to Joe Mertens, late in the day of the announcement he made us wait for a lot of customers and had their front line sellers and it would for the most part all positive. So again, we think I said the word before home run deal, and we're going to make it work really well and our customers seem to be excited. Our partners equally are thrilled. It's exactly what they were looking for us to do in there as well.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
I think what we've done is we have a fairly rigid and thoughtful capital allocation thesis. And we've explained it entirely to all of our operators at a senior level. And we've said here is the things that matter to us and here is how we're thinking about growing and here is how it matters to all of our stakeholders. And please keep your eye out the things that help us do that organically or inorganically.
And if we really continue to leverage the experience and knowledge of all of our leaders at Phreesia, we have a better -- our opportunities for executing, which is better and integrating are better and making anything [Phonetic] really have a shot of clear success. So our view is not do we have a lot of cash on the balance sheet. It's -- whether it was $200 million or $300 million of $450 million, we still have the same views on how we use the capital. And it's really to be used thoughtfully.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yeah. 55% to 60%, somewhere in that range.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Thanks, Rupert.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Along with not getting ourselves pregnant, recognizing the volatility of world these days, we also want to be conservative we don't want to get too far ahead of ourselves. And, approving too much capital, and having the bottom fall out of the global markets for a year or something.So we -- we are trying, we are doing this in a very safe way. We don't want to ever risk the company. But we do want to aggressively grow. So that's kind of, how we're balancing this.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Thanks, Paul, Sandeep, Eaun and Jason, and the team here. Great to see very strong Q4 and also great to see the dividend increase here. Maybe my first question is on energy as well, it's kind of funny, sometimes you don't want to talk about it, and now everyone wants to talk about it. Jason, I don't know if you have this handy in front of you, but could you maybe remind to be what percentage of your revenues sensitive to the different commodities? I know you have some exposure to WTI, exposure to AECO, exposure the WCS, exposure to Henry Hub, by what percentage are we talking about based on your revenue?

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Thanks, Ram.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Thanks, Mark.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Hey, Yaron, it's Ed. So our direct claims are in the range of $400 million to $500 million a quarter, and then we have reinsurance that may bring us down, let's say, in the neighborhood of $250 million in a more normal quarter. But if you focus on the direct claims of $400 million to $500 million in a typical quarter, we had closer to $600 million this quarter. So a portion of that is COVID as we discussed, and then a portion of it is just volatility that we see from time to time in our frequency and severity. And there is nothing that we see that's systemic. This was not a good quarter for mortality and it's going to bounce around. And we're talking about a number that's that large, obviously, movement in that number can have a meaningful impact on a quarterly's earnings.

    Prediction (one of UP, DOWN, SAME): DOWN
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yes. Thank you

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yes. I mean we're saying 2022 -- now, Jonathan, the Pennsylvania State Court or Commonwealth Court, that just takes time as we grind through the process. And so I would think that, that would be the case. I mean, just a little bit of color on this. There is an election in Delaware County, two of the ceded commissioners or counsel minute they call them in Delaware County are up for election. One of them is not running again. He was the Chairman, Mr. Zidek, and so he'll be replaced absolutely. And then there's another commissioner or counselman named Madden who's also up.
So there could be a change in the makeup of Delaware County Council. There will absolutely be a makeup at least a change in one seat, maybe two when we come into January, and they're seated immediately in January. It's like January three or something. So we will see some changes there. Might there be an opportunity with a new look and a new set of counsel people to find a settlement, you never know.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Hi, good morning. Just a question on the balance sheet and turning more offensive, which you touched on in your prepared remarks. Do you foresee that being more ramping up developments and redevelopments that were maybe postponed as a result of COVID? Or are you seeing interesting external acquisitions? And if so, are those more for stabilized assets or redevelopment opportunities where maybe the yield is a bit user kind of once you think about the long-term prospects for that asset?

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
No, it really does not signal anything about where we sit with M&A that Chris and I work very closely to model scenarios and our ability to drive acquisitions. And we still very much have a lot of dry powder and are able to move on acquisitions as they become available. We planned for that to be in coincidence with the purchase buyback that we have done so far.

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Thank you. Good morning, everybody. My first question goes to the increase in the buyback authorization. Less so about, I think, 2021, but the thought of, kind of, seeing that $0.5 billion increase flow through to your kind of three-year target.
I guess, conceptually, I want to maybe get your sense. Is that something that you think you'll be revisiting on a quarterly basis based on the performance of the company? Or is this kind of a one-off? How should we think of this new $10.5 billion target?

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yes. Europe is above pre-pandemic levels. And now, OK, to be fair, Europe wasn't all that hot in 2019. But it was -- it's still clearly above the pre-pandemic levels.
In other words, it's offset whatever the impact of the pre-pandemic was. Tools group is pretty much across all geographies, which is kind of interesting because right now stimulus in the U.K. and Australia and Canada.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Thanks, Rick.

    Prediction (one of UP, DOWN, SAME): DOWN
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yes. Thank you, Puneet. So maybe starting by the last question on biopharma. Yes. Our funnel is very strong around biopharma is simply -- it's clear that there is big interest in what we offer on this cover an optimization because our antibodies are for human and even derived on day one. As far as when will the first swift antibody go into clinic. We don't have a clear timing on that because our partner filing to do that. And we mentioned on the call that we have main programs that are out of our hands, meaning that that now the partners is in charge of the timing. And so it's just a question of time until a this antibody is exciting. But to be clear, our partners will be doing the work. In terms of the liquid biopsy question, we were definitely in the number of liquid biopsy products. We can only talk publicly about GRAIL because they mentioned using Twist exclusively. We can't discuss other customers that have not mentioned with. But we are -- in the past, we have won more than our fair share of bake-offs. And we can see in the revenues that keep coming quarter-over-quarter after quarter that those liquid companies are burning source billing DNA to do their work of validating product evaluating their assay in anticipation of a commercial launch. So that's why we're quite bullish on the long-term prospect of LT NGS pipeline because as those products go commercial, that should enable us to get continued revenue ramp.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Thank you, Sam.

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yeah. Sure. Tim, this is Brett, by the way. Your math is accurate there. It does imply an improvement in our run rate off of our Q3 exit rate here. The primary driver of that is related to staffing improvements that I commented on in the prepared remarks. We've seen a nice improvement in our staffing levels to model and as a result of that, we've seen that translate into improved completion rates of our recurring revenue that's translated into higher revenue growth. So, we feel confident in the guide given that improving labor backdrop that we've seen in October.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Okay. Thanks very much.

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Thanks a lot for taking the question. I have one that's somewhat specific to REPAY, also sort of an industry question. And then last one is a follow-up on the origination. So, for the industry one, just want to dig in a little bit into the value proposition. So, when a supplier is offered the various choices to accept payment, enhanced ACH being one of them, maybe at some point down the line enhanced ACH could be working with RTP or a faster payment rail rather than a traditional ACH, but, regardless, if we put one bucket of the enhanced ACH and the other of the virtual card and big picture if we think about components around data and messaging and reconciliation and the other one being speed of settlement and the money goodness, if you will, of the payment, when the suppliers are given the choice of those two, what are the considerations? In other words, why does someone opt for a virtual card rather than ACH at various times?

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Sure. So for the glass, it's a relatively new issue, and it's primarily in U.K. and Continental Europe. So the glass suppliers, there's two suppliers that have float lines that manufacture the glass that have gone down and they're on force majeure with the customers on allocation.
Now obviously, we don't buy that, but any of our window and door customers that use glass, it will impact their ability to manufacture. So there's restricted capacity in both the U.K. and Europe for glass. It's mainly a European issue.
As it is being relatively new, there's very little of that impact baked into our guidance. What's baked into our guidance is what we're being told now. So the only comment being is that that situation worsens and something else were to happen unexpectedly, that could have an impact. And that is not baked into our guidance.

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yeah, I think, I said quarters ago that we were going to invest in people and I just wanted to respond with, hey, this is -- this is what we've been doing, these are -- several in these group are upgrades, but most of them are just additions. And you know, I think there's a lot of runway with this group right here, specifically. But we will never take our eye off the ball and continue to invest in people.
I mean, we're in the people business the disruption is only going to get greater with what with the big PNC-BBVA deal. We're already seeing that disruption. And I saw yester -- I read this morning, a new bank -- holding company is moving to Dallas from California. It's just going to get more disruptive. And so, people are what make the difference. And we're talking to some right now that could continue to move the needle for us.

    Prediction (one of UP, DOWN, SAME): DOWN
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yes. I think over the long term, it will present cost savings for us, but any change in the supply chain, especially in sterile eye care, takes a very, very long period of time. The seller -- we entered into a long-term supply agreement with the seller of the brands with Akorn, which we're delighted to have. So we'll see where it goes over the long term for cost-savings opportunity, but it really all starts with having a great partner, which we got as part of this transaction.

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
That's right. So as we said, we had about 77 basis points of deleverage this quarter, about 40% of that was related to supply chain costs and the other -- roughly 40 basis point is the supply chain costs and the remainder is the initiatives that we talked about. And what I'll say about our outlook in the future is that we're going to continue to lean into the strategy that we -- that we have today. Because in this environment, what we're seeing is, it's working. We're getting topline, we're getting EBIT dollar growth, and we're going to lean into that as we move forward. So we won't be date-certain necessarily about when you will see an inflection point, because we're in the early innings of this strategy and its delivering for us.

    Prediction (one of UP, DOWN, SAME): SAME